[
  {
    "ts": "2025-10-04T14:12:51+00:00",
    "headline": "Why Analysts Believe the Story for Charles River Labs Is Shifting After Recent Strategic Moves",
    "summary": "The consensus analyst price target for Charles River Laboratories International has seen a modest uptick, rising from $177.07 to $179.73. This slight increase reflects growing optimism around the company's recent financial performance and its active strategic review efforts. However, there is still lingering caution tied to uncertain long-term prospects. Stay tuned to find out how investors can keep track of evolving analyst expectations and changes in the company's outlook moving...",
    "url": "https://finance.yahoo.com/news/why-analysts-believe-story-charles-141251512.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "f988bbea-7983-3a70-9f45-cc6e1d751c7f",
      "content": {
        "id": "f988bbea-7983-3a70-9f45-cc6e1d751c7f",
        "contentType": "STORY",
        "title": "Why Analysts Believe the Story for Charles River Labs Is Shifting After Recent Strategic Moves",
        "description": "",
        "summary": "The consensus analyst price target for Charles River Laboratories International has seen a modest uptick, rising from $177.07 to $179.73. This slight increase reflects growing optimism around the company's recent financial performance and its active strategic review efforts. However, there is still lingering caution tied to uncertain long-term prospects. Stay tuned to find out how investors can keep track of evolving analyst expectations and changes in the company's outlook moving...",
        "pubDate": "2025-10-04T14:12:51Z",
        "displayTime": "2025-10-04T14:12:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0Ih9Jyeb4E8RAOq22ZtFHA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r5jgPUxQrxmcesBmGBKgkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-analysts-believe-story-charles-141251512.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-analysts-believe-story-charles-141251512.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-04T12:31:03+00:00",
    "headline": "Charles River price target raised to $200 from $190 at Evercore ISI",
    "summary": "Evercore ISI analyst Elizabeth Anderson raised the firm’s price target on Charles River (CRL) to $200 from $190 and keeps an Outperform rating on the shares. The firm’s survey work points to a positive outlook for preclinical CROs, with rising budgets and declining cancellations, along with suggesting stable demand for discovery and toxicology services into 2025 and 2026, the analyst tells investors in a note on the group. Published first on TheFly – the ultimate source for real-time, market-mov",
    "url": "https://finance.yahoo.com/news/charles-river-price-target-raised-123103893.html",
    "source": "TipRanks",
    "provider": "yfinance",
    "raw": {
      "id": "bf8d27e5-c355-3463-ac7e-54f2475801dd",
      "content": {
        "id": "bf8d27e5-c355-3463-ac7e-54f2475801dd",
        "contentType": "STORY",
        "title": "Charles River price target raised to $200 from $190 at Evercore ISI",
        "description": "",
        "summary": "Evercore ISI analyst Elizabeth Anderson raised the firm’s price target on Charles River (CRL) to $200 from $190 and keeps an Outperform rating on the shares. The firm’s survey work points to a positive outlook for preclinical CROs, with rising budgets and declining cancellations, along with suggesting stable demand for discovery and toxicology services into 2025 and 2026, the analyst tells investors in a note on the group. Published first on TheFly – the ultimate source for real-time, market-mov",
        "pubDate": "2025-10-04T12:31:03Z",
        "displayTime": "2025-10-04T12:31:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/tipranks_452/4228d494699edc69b7f529ca87ad9ce2",
          "originalWidth": 192,
          "originalHeight": 192,
          "caption": "https://www.tipranks.com/news/the-fly/charles-river-price-target-raised-to-200-from-190-at-evercore-isi-thefly",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RZtUtufHHhxezi_Nqr4sSg--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/4228d494699edc69b7f529ca87ad9ce2.cf.webp",
              "width": 192,
              "height": 192,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HQoKSNjotRlKkUICZ18HnA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/4228d494699edc69b7f529ca87ad9ce2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "TipRanks",
          "url": "https://www.tipranks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-price-target-raised-123103893.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-price-target-raised-123103893.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]